Annual Cash & Cash Equivalents
$41.67 M
-$44.43 M-51.61%
December 31, 2024
Summary
- As of March 12, 2025, EWTX annual cash & cash equivalents is $41.67 million, with the most recent change of -$44.43 million (-51.61%) on December 31, 2024.
- During the last 3 years, EWTX annual cash & cash equivalents has risen by +$26.10 million (+167.67%).
- EWTX annual cash & cash equivalents is now -60.29% below its all-time high of $104.92 million, reached on December 31, 2020.
Performance
EWTX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$41.67 M
-$3.14 M-7.01%
December 31, 2024
Summary
- As of March 12, 2025, EWTX quarterly cash and cash equivalents is $41.67 million, with the most recent change of -$3.14 million (-7.01%) on December 31, 2024.
- Over the past year, EWTX quarterly cash and cash equivalents has dropped by -$3.14 million (-7.01%).
- EWTX quarterly cash and cash equivalents is now -81.15% below its all-time high of $221.04 million, reached on March 31, 2021.
Performance
EWTX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
EWTX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -51.6% | -7.0% |
| 3 y3 years | +167.7% | +26.4% |
| 5 y5 years | +76.2% | +26.4% |
EWTX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -51.6% | +167.7% | -62.0% | +167.7% |
| 5 y | 5-year | -60.3% | +167.7% | -81.2% | +294.1% |
| alltime | all time | -60.3% | +167.7% | -81.2% | +294.1% |
Edgewise Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $41.67 M(-51.6%) | $41.67 M(-7.0%) |
| Sep 2024 | - | $44.81 M(+3.0%) |
| Jun 2024 | - | $43.48 M(+43.7%) |
| Mar 2024 | - | $30.26 M(-64.8%) |
| Dec 2023 | $86.10 M(+291.5%) | $86.10 M(+161.2%) |
| Sep 2023 | - | $32.96 M(+3.6%) |
| Jun 2023 | - | $31.81 M(-34.1%) |
| Mar 2023 | - | $48.23 M(+119.3%) |
| Dec 2022 | $21.99 M | $21.99 M(-80.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $109.75 M(+498.4%) |
| Jun 2022 | - | $18.34 M(-46.8%) |
| Mar 2022 | - | $34.45 M(+121.3%) |
| Dec 2021 | $15.57 M(-85.2%) | $15.57 M(+47.3%) |
| Sep 2021 | - | $10.57 M(-79.0%) |
| Jun 2021 | - | $50.40 M(-77.2%) |
| Mar 2021 | - | $221.04 M(+110.7%) |
| Dec 2020 | $104.92 M(+343.6%) | $104.92 M |
| Dec 2019 | $23.65 M | - |
FAQ
- What is Edgewise Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Edgewise Therapeutics?
- What is Edgewise Therapeutics annual cash & cash equivalents year-on-year change?
- What is Edgewise Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Edgewise Therapeutics?
- What is Edgewise Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Edgewise Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of EWTX is $41.67 M
What is the all time high annual cash & cash equivalents for Edgewise Therapeutics?
Edgewise Therapeutics all-time high annual cash & cash equivalents is $104.92 M
What is Edgewise Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, EWTX annual cash & cash equivalents has changed by -$44.43 M (-51.61%)
What is Edgewise Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of EWTX is $41.67 M
What is the all time high quarterly cash and cash equivalents for Edgewise Therapeutics?
Edgewise Therapeutics all-time high quarterly cash and cash equivalents is $221.04 M
What is Edgewise Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, EWTX quarterly cash and cash equivalents has changed by -$3.14 M (-7.01%)